January 21, 2014
March 18, 2014
November 7, 2011
March 13, 2014
Hasenstab in Ukraine, on UkraineApril 9, 2014
"Being on the ground, understanding the situation, seeing the long-term potential—that’s why we are investing in Ukraine. "
"From our viewpoint at Franklin Equity Group®, US stocks have acted rationally over the last five years, reflecting the improving economic backdrop and strong corporate earnings growth we see. "
It took a while, but investors finally seem to have shaken off some of the lingering fear that has plagued the US equity market since the ...
"We wouldn’t anticipate a dramatic reaction from the US economy to higher rates, particularly if they come gradually, which is what we’d expect."
When the US Federal Reserve (Fed) began tapering early this year, the general assumption was that investors would flee en masse from fixed income ...
Many investors who have never traveled in Africa probably have preconceived ideas about it, perhaps as a land of safaris and political strife, ...
"We recognize there are global uncertainties in the markets right now that will cause investors to worry at times. When those worries are enough to cause selling, as we see it, that’s where the opportunity comes in."
Given continued unrest in Ukraine, crippling winter storms and Federal Reserve “tapering” in the United States, and concerns about growth in ...
"We are still finding plenty of reasons to be optimistic about the global equity outlook this year, and we are still finding values."
Maintaining the right mix or balance of assets in a portfolio to achieve a desired goal can be a challenge, particularly when the markets are ...
"Currently, there are many exciting products in the pharmaceutical and biotech space producing clinical data that show a meaningful change for patients."
A wave of exciting new developments in the biotech and pharmaceutical industries caught the attention of investors in 2013, boosting many stocks ...